TOTAL VOLUME:

$154.4b

24H VOL:

$290,393,159

24H TRANSACTIONS:

2,984,640,614

OPEN INTEREST:

$1,944,100,805

420,493

Markets across

40,511

events

MATCHED EVENTS:

4,612

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Tour
All
Sports
Utah vs Edmonton: 3rd Period Total
kalshi

Utah vs Edmonton: 3rd Period Total

Volume:
$5,977

Over 1.5 goals

 - Kalshi

Over 1.5 goals - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Oct 15, 2026

Closed: Oct 15, 11:45 PM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Over 1.5 goals

View
100%
Yes 100¢No 0¢
—
N/A
$2,060
N/A
N/A
$1,931
Settled
Yes
kalshi

Over 0.5 goals

100%
Yes 100¢No 0¢
—
N/A
$911
N/A
N/A
$911
Settled
Yes
kalshi

Over 2.5 goals

0%
Yes 0¢No 100¢
—
N/A
$2,385
N/A
N/A
$1,880
Settled
No
kalshi

Over 3.5 goals

0%
Yes 0¢No 100¢
—
N/A
$391
N/A
N/A
$303
Settled
No
kalshi

Over 4.5 goals

0%
Yes 0¢No 100¢
—
N/A
$230
N/A
N/A
$230
Settled
No
kalshi

Over 5.5 goals

N/A
N/A
—
N/A
N/A
N/A
N/A
N/A
Settled
No
Total markets: 6

Description

These markets track how many goals are scored in the third period of an NHL hockey game between Utah and Edmonton. Each market corresponds to a different threshold of goals, determining whether the scoring exceeds that threshold in that specific period.

Kalshi

All markets resolve based on the total number of goals scored by both teams in the third period of the Utah vs Edmonton NHL game scheduled for October 15, 2026, with each market having a distinct threshold (0.5, 1.5, or 2.5 goals) for resolving to 'Yes.' Overtime goals are excluded from all markets. If the game is postponed but starts within 48 hours of the original time, the markets remain active and resolve according to the final official result. If the game is cancelled or does not start within 48 hours of its scheduled time, all markets resolve to a fair price, ensuring equitable treatment for all participants.